Therapeutic Potential of Neurogenesis for Prevention and Recovery from Alzheimer's Disease: Allopregnanolone as a Proof of Concept Neurogenic Agent

Publisher： Bentham Science Publishers

E-ISSN： 1875-5828|3|3|185-190

ISSN： 1567-2050

Source： Current Alzheimer Research, Vol.3, Iss.3, 2006-07, pp. : 185-190

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Regeneration in a Degenerating Brain: Potential of Allopregnanolone as a Neuroregenerative Agent

By  

Current Alzheimer Research, Vol. 4, Iss. 5, 2007-12 ,pp. : 510-517

Bentham Science Publishers

Access to resources Recommend Favorite

Potential use of estrogen-like drugs for the prevention of Alzheimer’s disease

By Smith Jonathan   Levin-Allerhand Justine  

Journal of Molecular Neuroscience, Vol. 20, Iss. 3, 2003-08 ,pp. : 277-281

Humana Press, Inc

Access to resources Recommend Favorite

Detrimental Effects of Apolipoprotein E4: Potential Therapeutic Targets in Alzheimer's Disease

By  

Current Alzheimer Research, Vol. 4, Iss. 5, 2007-12 ,pp. : 537-540

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutic potential of amyloid &bgr;-degrading enzymes in Alzheimer’s disease

By Gan Li  

Future Neurology, Vol. 2, Iss. 2, 2007-03 ,pp. : 133-137

Future Medicine

Access to resources Recommend Favorite

Gonadotropins: potential targets for preventive and therapeutic interventions in Alzheimer’s disease

By Barron Anna M   Verdile Giuseppe   Martins Ralph N  

Future Neurology, Vol. 1, Iss. 2, 2006-03 ,pp. : 189-202

Future Medicine

Access to resources Recommend Favorite